Cosmos Holdings Inc. (COSM)

NASDAQ: COSM · IEX Real-Time Price · USD
1.05
-0.07 (-6.25%)
At close: May 24, 2022 3:59 PM
1.07
0.02 (1.90%)
After-hours:May 24, 2022 5:40 PM EDT
Market Cap19.66M
Revenue (ttm)57.69M
Net Income (ttm)-19.01M
Shares Out18.72M
EPS (ttm)-1.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume97,733
Open1.13
Previous Close1.12
Day's Range1.00 - 1.13
52-Week Range0.75 - 7.77
Beta1.13
Analystsn/a
Price Targetn/a
Earnings DateMay 16, 2022

About COSM

Cosmos Holdings Inc. operates as a vertically integrated pharmaceutical company. It offers proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter (OTC) medications, health care, baby products, medical devices, and other products through its distribution channels and e-commerce market place. The company identifies, acquires, develops, and commercializes products that enhance patients' lives and outcomes, as well as has distribution centers in Greece, and the United Kingdom; and warehousing facility. It serves w...

IndustryHealth Care Providers & Services
IPO DateDec 13, 2013
CEOGrigorios Siokas
Employees95
Stock ExchangeNASDAQ
Ticker SymbolCOSM
Full Company Profile

Financial Performance

Financial Statements

News

Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the ...

Reports Positive Net Income of $0.2 Million and $1.2 Million of EBITDA for the First Quarter of 2022 CHICAGO, IL / ACCESSWIRE / May 18, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an in...

6 days ago - Accesswire

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Canada

First commercial launch of nutraceutical products in North American Market CHICAGO, IL / ACCESSWIRE / May 5, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical ...

2 weeks ago - Accesswire

Cosmos Holdings Appoints Finance Veteran Dr. Anastasios Aslidis to the Board of Directors and as a Member of the Boar...

CHICAGO, IL / ACCESSWIRE / May 3, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of brande...

Other symbols:ESEA
3 weeks ago - Accesswire

COSM Stock Alert: 7 Things to Know About Red-Hot Cosmos Holdings

Cosmos Holdings (COSM) stock is seeing major gains on Wednesday with heavy trading despite a lack of recent news from the company. The post COSM Stock Alert: 7 Things to Know About Red-Hot Cosmos Holdin...

3 weeks ago - InvestorPlace

Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading

Here's what you need to know about trading penny stocks on April 27th The post Best Penny Stocks to Buy Today? 3 Climbing In Morning Trading  appeared first on Penny Stocks to Buy, Picks, News and Infor...

Other symbols:AFIBKTRA
3 weeks ago - PennyStocks

Cosmos Holdings Reports Continued Revenue Growth and Achieves $3.3 Million of Adjusted EBITDA for the Fiscal Year 2021

CHICAGO, IL / ACCESSWIRE / April 19, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...

1 month ago - Accesswire

Cosmos Holdings Launches Mediterranation, a New Premium Nutritional Supplements Line

New line contains unique formulations and ingredients found in specific regions in Greece and the Mediterranean CHICAGO, IL / ACCESSWIRE / April 12, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:...

1 month ago - Accesswire

Cosmos Holdings to Launch Sky Premium Life Nutritional Supplements on Amazon Singapore

CHICAGO, IL / ACCESSWIRE / April 5, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...

1 month ago - Accesswire

Cosmos Holdings Launches Proprietary Sky Premium Life Brainlit Supplement for Brain Health

Designed to support and enhance brain function CHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietar...

1 month ago - Accesswire

Cosmos Holdings Launches Proprietary Sky Premium Life Prostatium Supplement for Prostate Health

Designed to prevent and protect against Benign Prostate Hyperplasia, which affects millions of men worldwide CHICAGO, IL / ACCESSWIRE / March 28, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COS...

1 month ago - Accesswire

Cosmos Holdings to Present at the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest

CHICAGO, IL / ACCESSWIRE / March 24, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...

2 months ago - Accesswire

Cosmos Holdings CEO Provides Letter to Shareholders

CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...

2 months ago - Accesswire

Cosmos Holdings to Ring Closing Bell Today to Celebrate Milestone NASDAQ Listing

CHICAGO, IL / ACCESSWIRE / March 11, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM) , an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bra...

2 months ago - Accesswire

Cosmos Holdings Announces Closing of $6 Million Private Placement of Convertible Preferred Stock and Start of Trading...

CHICAGO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (Nasdaq: COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...

2 months ago - GlobeNewsWire

Cosmos Holdings Announces Shareholder Approval of Private Offering

CHICAGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc.  (“the Company") (OTCQX:  COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of br...

5 months ago - GlobeNewsWire

Cosmos Holdings Achieves Positive Adjusted Net Income and Positive Adjusted EBITDA for the Third Quarter of 2021

CHICAGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...

6 months ago - GlobeNewsWire

Cosmos Holdings Announces Installation of State-of-the-Art Automated Fulfillment System to Maximize the Productivity ...

CHICAGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of bran...

6 months ago - GlobeNewsWire

Cosmos Holdings Secures $5.5M Investment From Ault Global

Ault Global Holdings Inc (NYSE: DPW) subsidiary entered into agreements for investments of ~$5.5 million in pharmaceutical company Cosmos Holdings, Inc. (OTC: COSM). The first investment, a convertible ...

8 months ago - Benzinga

UPDATE - Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing Received initial bridge financing for...

8 months ago - GlobeNewsWire

Cosmos Holdings Secures Approximately $5.5 Million Investment from Ault Global Holdings

Received initial bridge financing for proceeds of approximately $500,000 plus an additional $5.0 million of Series A Preferred Stock upon approval of Nasdaq listing Received initial bridge financing for...

8 months ago - GlobeNewsWire

Cosmos Holdings Announces Voluntary Conversion of Debt to Equity by the Company's Senior Lender, Further Enhancing th...

CHICAGO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), an international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, n...

9 months ago - GlobeNewsWire

Cosmos Holdings Reports 15.8% Year-Over-Year Growth and 27.8% Sequential Increase in Revenue for the Second Quarter o...

CHICAGO, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Cosmos Holdings, Inc. (“the Company") (OTCQX: COSM ), international pharmaceutical company with a proprietary line of branded and generic pharmaceuticals, nutr...

9 months ago - GlobeNewsWire

Cosmos Holdings to Open Flagship Store on Alibaba's Tmall Global, World's Largest Cross-Border E-Commerce Marketplace...

Company Partners with Leading China E-Commerce Solutions Provider REMAI to Launch Sky Premium Life Products on Tmall Global Company Partners with Leading China E-Commerce Solutions Provider REMAI to Lau...

9 months ago - GlobeNewsWire

Cosmos Holdings CEO Greg Siokas Converts an Additional $1.25 Million of Debt into Common Stock at $6.00 Per Share

CEO has converted $4.0 million of the Company's debt to date; the conversion price represents a premium to market CEO has converted $4.0 million of the Company's debt to date; the conversion price repre...

9 months ago - GlobeNewsWire

Cosmos Holdings CEO Greg Siokas Converts an Additional $1.0 Million of Debt into Common Stock at $6.00 Per Share

The conversion price represents a premium to market The conversion price represents a premium to market

10 months ago - GlobeNewsWire